Condition
Steroid-refractory Acute Graft-versus-host Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Steroid-refractory Acute Graft-versus-host Disease clinical trials that are recruiting, at sites in 6 countries (most in France (1), Germany (1), Poland (1)). By phase: Phase 3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
Moxibustion with second-line treatment for steroid-refractory acute graft-versus-host disease after transplant
This study will test whether adding moxibustion to standard second-line drug therapy helps people aged 14–65 with steroid-refractory gastrointestinal acute GVHD after an allogeneic stem cell transplant.
-
Treatment for steroid-refractory acute graft-versus-host disease using mesenchymal stromal cells
This study is testing a new type of cell therapy to see if it can help adults and teens with a tough form of graft-versus-host disease that hasn't improved with standard treatments.
Related topics
Quick answers
How many Steroid-refractory Acute Graft-versus-host Disease clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in France (1 trial), Germany (1 trial), Poland (1 trial), Spain (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.